VDAC1 selective molecules promote patients-derived cancer organoids death through mitochondrial-dependent metabolic interference
S. Conti Nibali, S. De Siervi, A. Magri, L. Brocca, S. Mantovani, B. Oliviero, M. U. Mondelli, V. De Pinto, C. Turato, C. Arrigoni, M. Lolicato
This paper identifies VA molecules that selectively target VDAC1 in cancer cells, causing mitochondrial distress and reduced viability, with less impact on healthy cells.
bioRxiv · Dec 4, 2023 · PreprintBiophysics